August 09, 2025 a 07:43 pm
MDT: Fundamental Ratio Analysis - Medtronic plc
Medtronic plc operates at the forefront of medical technology, providing diverse medical devices and therapies globally. The company's robust portfolios in cardiovascular, medical surgery, neuroscience, and diabetes sectors highlight its comprehensive approach to healthcare solutions, but investors should be mindful of its fluctuating financial metrics.
Fundamental Rating
The fundamental rating of Medtronic plc positions it as a stable yet not overly aggressive player in the market, with room for enhancement in financial strength.
| Metric | Score | Visualization |
|---|---|---|
| Overall Score | 3 | |
| Discounted Cash Flow | 4 | |
| Return On Equity | 4 | |
| Return On Assets | 4 | |
| Debt To Equity | 2 | |
| Price To Earnings | 2 | |
| Price To Book | 3 |
Historical Rating
The historical ratings of Medtronic plc illustrate consistent scoring in several key areas, signaling stability but with little progressive enhancement.
| Date | Overall | DCF | ROE | ROA | Debt/Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-08-08 | 3 | 4 | 4 | 4 | 2 | 2 | 3 |
| Previous | 0 | 4 | 4 | 4 | 2 | 2 | 3 |
Analyst Price Targets
Analyst price targets for Medtronic plc suggest a mixed forecast, with a wide range between the high and low predictions, indicating differing opinions on future performance.
| High | Low | Median | Consensus |
|---|---|---|---|
| $165 | $80 | $101 | $107.29 |
Analyst Sentiment
The analyst sentiment towards Medtronic plc exhibits a strong inclination to buy, although a significant portion remains cautious with a 'hold' stance.
| Recommendation | Count | Distribution |
|---|---|---|
| Strong Buy | 1 | |
| Buy | 27 | |
| Hold | 21 | |
| Sell | 0 | |
| Strong Sell | 0 |
Conclusion
Medtronic plc stands as a key entity within the medical devices sector, offering resilient solutions across multiple health-related portfolios. While its financial scores suggest reliable performance, some areas like Debt/Equity reveal vulnerabilities. The broad difference in analyst price targets reflects uncertainty, though the prevalent Buy consensus indicates perceived value. Potential investors should weigh these factors against market volatility and industry risks.